Inhaled Coronavirus Vaccine That Delivers Drug Directly to Airways to Be Trialled

noseAtrial to see if an inhaled coronavirus vaccine would be more effective than one delivered via injection is starting in the U.K. A small trial of 30 people will see participants inhale either the Oxford Vaccine, which is currently being developed by AstraZeneca and in the Phase III of testing, or the saRNA vaccine by Imperial College London, U.K. It is thought that by targeting the airways directly…. newsweek